Lactose drives Enterococcus expansion to promote graft-versus-host disease

QIIME allows analysis of high-throughput community sequencing data

Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 20,966 · see citing works

Metagenomic biomarker discovery and explanation

Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · see citing works

Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB

DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891 · see citing works

VSEARCH: a versatile open source tool for metagenomics

(2016) · doi:10.7717/peerj.2584 · Cited by 10,773 · see citing works

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · see citing works

RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes

Brettin, T. S., Davis, J. J., Disz, T. L., Edwards, R. A., Gerdes, S., Olsen, G. J., Olson, R., Overbeek, R., Parrello, B., Pusch, G. D., et al. (2015) · Scientific Reports · doi:10.1038/srep08365 · Cited by 2,830 · see citing works

Dysbiosis and the immune system

Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769 · see citing works

Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease

Palm, N. W., de Zoete, M. R., Cullen, T. W., Barry, N. A., Stefanowski, J., Hao, L., Degnan, P. H., Hu, J., Peter, I., Zhang, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.006 · Cited by 1,286 · see citing works

Strains, functions and dynamics in the expanded Human Microbiome Project

Lloyd-Price, J., Mahurkar, A., Rahnavard, G., Crabtree, J., Orvis, J., Hall, A. B., Brady, A., Creasy, H. H., McCracken, C., Giglio, M. G., et al. (2017) · Nature · doi:10.1038/nature23889 · Cited by 1,267 · see citing works

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

Lindemans, C. A., Calafiore, M., Mertelsmann, A. M., O'Connor, M. H., Dudakov, J. A., Jenq, R. R., Velardi, E., Young, L. F., Smith, O. M., Lawrence, G., et al. (2015) · Nature · doi:10.1038/nature16460 · Cited by 1,112 · see citing works

Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Taur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y. J., Dubin, K. A., Socci, N. D., Viale, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis580 · Cited by 1,020 · see citing works

Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans

Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943 · see citing works

Genomic variation landscape of the human gut microbiome

Schloissnig, S., Arumugam, M., Sunagawa, S., Mitreva, M., Tap, J., Zhu, A., Waller, A., Mende, D. R., Kultima, J. R., Martin, J., et al. (2013) · Nature · doi:10.1038/nature11711 · Cited by 907 · see citing works

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

Taur, Y., Jenq, R. R., Perales, M.-A., Littmann, E. R., Morjaria, S., Ling, L., No, D., Gobourne, A., Viale, A., Dahi, P. B., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554725 · Cited by 885 · see citing works

Translocation of a gut pathobiont drives autoimmunity in mice and humans

Vieira, S. M., Hiltensperger, M., Kumar, V., Zegarra-Ruiz, D. F., Dehner, C. A., Khan, N., Costa, F. R. C., Tiniakou, E., Greiling, T. M., Ruff, W. E., et al. (2018) · Science · doi:10.1126/science.aar7201 · Cited by 843 · see citing works

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765 · see citing works

Colonocyte metabolism shapes the gut microbiota

Litvak, Y., Byndloss, M. X., & Bäumler, A. J. (2018) · Science · doi:10.1126/science.aat9076 · Cited by 765 · see citing works

Mining the Human Gut Microbiota for Immunomodulatory Organisms

Geva-Zatorsky, N., Sefik, E., Kua, L., Pasman, L., Tan, T. G., Ortiz-Lopez, A., Yanortsang, T. B., Yang, L., Jupp, R., Mathis, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.022 · Cited by 762 · see citing works

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

Jenq, R. R., Taur, Y., Devlin, S. M., Ponce, D. M., Goldberg, J. D., Ahr, K. F., Littmann, E. R., Ling, L., Gobourne, A. C., Miller, L. C., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.04.016 · Cited by 748 · see citing works

Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

Mathewson, N. D., Jenq, R., Mathew, A. V., Koenigsknecht, M., Hanash, A., Toubai, T., Oravecz-Wilson, K., Wu, S.-R., Sun, Y., Rossi, C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3400 · Cited by 725 · see citing works

Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2008) · Nature · doi:10.1038/nature07250 · Cited by 631 · see citing works

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

Jenq, R. R., Ubeda, C., Taur, Y., Menezes, C. C., Khanin, R., Dudakov, J. A., Liu, C., West, M. L., Singer, N. V., Equinda, M. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112408 · Cited by 626 · see citing works

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Shono, Y., Docampo, M. D., Peled, J. U., Perobelli, S. M., Velardi, E., Tsai, J. J., Slingerland, A. E., Smith, O. M., Young, L. F., Gupta, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2311 · Cited by 592 · see citing works

Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

Holler, E., Butzhammer, P., Schmid, K., Hundsrucker, C., Koestler, J., Peter, K., Zhu, W., Sporrer, D., Hehlgans, T., Kreutz, M., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.01.030 · Cited by 544 · see citing works

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders

Gill, P. A., van Zelm, M. C., Muir, J. G., & Gibson, P. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14689 · Cited by 520 · see citing works

Lactose digestion and the evolutionary genetics of lactase persistence

Ingram, C. J. E., Mulcare, C. A., Itan, Y., Thomas, M., & Swallow, D. M. (2008) · Human Genetics · doi:10.1007/s00439-008-0593-6 · Cited by 502 · see citing works

Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy

Kau, A. L., Planer, J. D., Liu, J., Rao, S. M., Yatsunenko, T., Trehan, I., MANARY, M. J., Liu, T., Stappenbeck, T. S., Maleta, K. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4877 · Cited by 373 · see citing works

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant

Taur, Y., Coyte, K. Z., Schlüter, J., Robilotti, E. V., Figueroa, C. J., Gjonbalaj, M., Littmann, E. R., Ling, L., Miller, L., Gyaltshen, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap9489 · Cited by 370 · see citing works

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.

Nestel, F. P., Price, K. S., Seemayer, T. A., & Lapp, W. S. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.2.405 · Cited by 365 · see citing works

Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation

Steck, N., Hoffmann, M., Sava, I. G., Kim, S. C., Hahne, H., Tonkonogy, S. L., Mair, K., Krueger, D., Pruteanu, M., Shanahan, F., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.035 · Cited by 343 · see citing works

IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote T H 17-dependent inflammation

Viladomiu, M., Kivolowitz, C., Abdulhamid, A., Dogan, B., Victorio, D., Castellanos, J. G., Woo, V., Teng, F., Tran, N. L., Sczesnak, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9655 · Cited by 314 · see citing works

Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium

Caballero, S., Kim, S., Carter, R. A., Leiner, I. M., Sušac, B., Miller, L., Kim, G. J., Ling, L., & Pamer, E. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.002 · Cited by 308 · see citing works

Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era

Gilmore, M. S., Lebreton, F., & van Schaik, W. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.01.006 · Cited by 301 · see citing works

Tracing the Enterococci from Paleozoic Origins to the Hospital

Lebreton, F., Manson, A. L., Saavedra, J. T., Straub, T. J., Earl, A. M., & Gilmore, M. S. (2017) · Cell · doi:10.1016/j.cell.2017.04.027 · Cited by 291 · see citing works

Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus

Kim, S. G., Becattini, S., Moody, T. U., Shliaha, P. V., Littmann, E. R., Seok, R., Gjonbalaj, M., Eaton, V. P., Fontana, E., Amoretti, L. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1501-z · Cited by 280 · see citing works

Impact of Gut Colonization With Butyrate-Producing Microbiota on Respiratory Viral Infection Following Allo-HCT

Haak, B. W., Littmann, E. R., Chaubard, J.-L., Pickard, A. J., Fontana, E., Adhi, F., Gyaltshen, Y., Ling, L., Morjaria, S. M., Peled, J. U., et al. (2018) · Blood · doi:10.1182/blood-2018-01-828996 · Cited by 273 · see citing works

Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation

Weber, D., Jenq, R. R., Peled, J. U., Taur, Y., Hiergeist, A., Koestler, J., Dettmer, K., Weber, M., Wolff, D., Hahn, J., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2017.02.006 · Cited by 245 · see citing works

Enterococci and Their Interactions with the Intestinal Microbiome

Dubin, K. A., & Pamer, E. G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0014-2016 · Cited by 235 · see citing works

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia

Galloway-Peña, J., Smith, D. P., Sahasrabhojane, P. V., Ajami, N. J., Wadsworth, W. D., Daver, N. G., Chemaly, R. F., Marsh, L., Ghantoji, S. S., Pemmaraju, N., et al. (2016) · Cancer · doi:10.1002/cncr.30039 · Cited by 189 · see citing works

IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract

Burman, A. C., Banovic, T., Kuns, R. D., Clouston, A. D., Stanley, A. C., Morris, E. S., Rowe, V., Bofinger, H. M., Skoczylas, R., Raffelt, N. C., et al. (2007) · Blood · doi:10.1182/blood-2006-12-063982 · Cited by 179 · see citing works

Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

Mowat, A. M. (1989) · PubMed Central · Cited by 170 · see citing works

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice

Staffas, A., da Silva, M. B., Slingerland, A. E., Lazrak, A., Bare, C. J., Holman, C. D., Docampo, M. D., Shono, Y., Durham, B. H., Pickard, A. J., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.03.002 · Cited by 144 · see citing works

Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease

Zhao, D., Kim, Y., Jeong, S., Greenson, J. K., Chaudhry, M. S., Hoepting, M., Anderson, E. R., van den Brink, M. R. M., Peled, J. U., Gomes, A. L. C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99261 · Cited by 141 · see citing works

Enterococcal Bacteremia Is Associated With Increased Risk of Mortality in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Vydra, J., Shanley, R., George, I., Ustun, C., Smith, A. R., Weisdorf, D. J., & Young, J. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis550 · Cited by 137 · see citing works

Improved survival after acute graft- versus -host disease diagnosis in the modern era

Khoury, H. J., Wang, T., Hemmer, M., Couriel, D., Alousi, A. M., Cutler, C. S., Aljurf, M. D., Antin, J. H., Ayas, M. F., Battiwalla, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.156356 · Cited by 113 · see citing works

Mitochondrial Sirtuin 4 Resolves Immune Tolerance in Monocytes by Rebalancing Glycolysis and Glucose Oxidation Homeostasis

Tao, J., Zhang, J., Ling, Y., McCall, C. E., & Liu, T. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00419 · Cited by 77 · see citing works

Simple, Reproducible, and Efficient Clinical Grading System for Murine Models of Acute Graft-versus-Host Disease

Naserian, S., Leclerc, M., Thiolat, A., Pilon, C., Bret, C. L., Belkacémi, Y., Maury, S., Charlotte, F., & Cohen, J. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00010 · Cited by 71 · see citing works

Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation

Webb, B. J., Healy, R., Majers, J., Burr, Z., Gazdik, M. A., Lopansri, B. K., Hoda, D., Petersen, F. B., & Ford, C. D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix232 · Cited by 61 · see citing works

Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes

Ford, C. D., Gazdik, M. A., Lopansri, B. K., Webb, B. J., Mitchell, B., Coombs, J., Hoda, D., & Petersen, F. B. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.017 · Cited by 54 · see citing works

A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation

Riesner, K., Kalupa, M., Shi, Y., Elezkurtaj, S., & Penack, O. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.279 · Cited by 47 · see citing works

Enterococci and Their Interactions with the Intestinal Microbiome

Dubin, K. A., & Pamer, E. G. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch13 · Cited by 43 · see citing works

Differential cytokine production associated with distinct phases of murine graft-versus-host reaction.

Garside, P., Reid, S. D., Steel, M., & Mowat, A. M. (1994) · PubMed Central · Cited by 29 · see citing works

Two-sample tests for growth curves under dependent right censoring

Vardi, Y., Ying, Z., & Zhang, C.-H. (2001) · Biometrika · doi:10.1093/biomet/88.4.949 · Cited by 28 · see citing works

Occurrence of d-tagatose-6-phosphate pathway of d-galactose metabolism among staphylococci

Schleifer, K. H., Hartinger, A., & Götz, F. (1978) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1978.tb01873.x · Cited by 16 · see citing works

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765 · see citing works

The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice

Wu, K., Yuan, Y., Yu, H., Dai, X., Wang, S., Sun, Z., Wang, F., Fei, H., Lin, Q., Jiang, H., et al. (2020) · Blood · doi:10.1182/blood.2019003990 · Cited by 345 · see citing works

<i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy

Griffin, M. E., Espinosa, J., Becker, J. L., Luo, J.-D., Carroll, T. S., Jha, J. K., Fanger, G. R., & Hang, H. C. (2021) · Science · doi:10.1126/science.abc9113 · Cited by 366 · see citing works

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Smith, M., Dai, A., Ghilardi, G., Amelsberg, K. V., Devlin, S. M., Pajarillo, R., Slingerland, J. B., Beghi, S., Herrera, P. S., Giardina, P., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01702-9 · Cited by 349 · see citing works

Acute graft-versus-host disease

Malard, F., Holler, E., Sandmaier, B. M., Huang, H., & Mohty, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00438-1 · Cited by 290 · see citing works

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Stein-Thoeringer, C. K., Saini, N. Y., Zamir, E., Blumenberg, V., Schubert, M.-L., Mor, U., Fante, M. A., Schmidt, S., Hayase, E., Hayase, T., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02234-6 · Cited by 255 · see citing works

Current Concepts and Advances in Graft-Versus-Host Disease Immunology

Hill, G. R., Betts, B. C., Tkachev, V., Kean, L. S., & Blazar, B. R. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102119-073227 · Cited by 198 · see citing works

Utilization of the microbiome in personalized medicine

Ratiner, K., Ciocan, D. M., Abdeen, S. K., & Elinav, E. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00998-9 · Cited by 178 · see citing works

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170 · see citing works

The Relationship Between Breast Milk Components and the Infant Gut Microbiota

Boudry, G., Charton, E., Huërou‐Luron, I. L., Ferret‐Bernard, S., Gall, S. L., Even, S., & Blat, S. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.629740 · Cited by 165 · see citing works

Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD

Blazar, B. R., Hill, G. R., & Murphy, W. J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0356-4 · Cited by 144 · see citing works

Role of the microbiota in response to and recovery from cancer therapy

Blake, S. J., Wolf, Y., Boursi, B., & Lynn, D. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00951-0 · Cited by 146 · see citing works

Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics

Wei, Y., Araya, D. P., & Palmer, K. L. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01058-6 · Cited by 146 · see citing works

Intestinal colonization resistance in the context of environmental, host, and microbial determinants

Woelfel, S., Silva, M. S., & Stecher, B. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.002 · Cited by 141 · see citing works

Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci

Werner, G., Neumann, B., Weber, R. E., Kresken, M., Wendt, C., Bender, J. K., Becker, K., Borgmann, S., Diefenbach, A., Hamprecht, A. G., et al. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100732 · Cited by 110 · see citing works

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients

Malard, F., Vekhoff, A., Lapusan, S., Isnard, F., D’Incan, E., Rey, J., Saillard, C., Thomas, X., Ducastelle-Leprêtre, S., Paubelle, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23376-6 · Cited by 102 · see citing works

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies

Xie, J., Liu, M., Deng, X., Tang, Y., Zheng, S., Ou, X., Tang, H., Xie, X., Wu, M., & Zou, Y. (2024) · iMeta · doi:10.1002/imt2.156 · Cited by 99 · see citing works

Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes

Liao, C., Rolling, T., Djuković, A., Fei, T., Mishra, V., Liu, H., Lindberg, C., Dai, L., Zhai, B., Peled, J. U., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01680-3 · Cited by 94 · see citing works

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

Ingham, A. C., Kielsen, K., Mordhorst, H., Ifversen, M., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2021) · Microbiome · doi:10.1186/s40168-021-01100-2 · Cited by 90 · see citing works

The human microbiome and cancer: a diagnostic and therapeutic perspective

Kandalai, S., Li, H., Zhang, N., Peng, H., & Zheng, Q. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2240084 · Cited by 93 · see citing works

Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus

Kaur, J. P., Cao, X., Abutaleb, N. S., Elkashif, A., Graboski, A. L., Krabill, A. D., AbdelKhalek, A., An, W., Bhardwaj, A., Seleem, M. N., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00734 · Cited by 86 · see citing works

Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics

Button, J. E., Autran, C. A., Reens, A. L., Cosetta, C. M., Smriga, S., Ericson, M. E., Pierce, J. V., Cook, D. N., Lee, M. L., Sun, A. K., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.04.001 · Cited by 85 · see citing works

Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species

Rolling, T., Zhai, B., Gjonbalaj, M., Tosini, N. L., Yasuma-Mitobe, K., Fontana, E., Amoretti, L. A., Wright, R. J., Ponce, D. M., Perales, M., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00989-7 · Cited by 83 · see citing works

Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML

Rashidi, A., Ebadi, M., Rehman, T. U., Elhusseini, H., Kazadi, D., Halaweish, H., Khan, M. H., Hoeschen, A. L., Cao, Q., Luo, X., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02366 · Cited by 84 · see citing works

Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure

Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 79 · see citing works

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

Khan, N., Lindner, S., Gomes, A. L. C., Devlin, S. M., Shah, G. L., Sung, A. D., Sauter, C. S., Landau, H. J., Dahi, P. B., Perales, M., et al. (2020) · Blood · doi:10.1182/blood.2020006923 · Cited by 80 · see citing works

Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease

da Silva, M. B., Ponce, D. M., Dai, A., Devlin, S. M., Gomes, A. L. C., Moore, G., Slingerland, J. B., Shouval, R., Armijo, G. K., DeWolf, S., et al. (2022) · Blood · doi:10.1182/blood.2021015352 · Cited by 81 · see citing works

Gut microbiota and sepsis: from pathogenesis to novel treatments

Kullberg, R. F. J., Wiersinga, W. J., & Haak, B. W. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000781 · Cited by 78 · see citing works

The role of the microbiota in the management of intensive care patients

Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J., & Ruppé, É. (2022) · Annals of Intensive Care · doi:10.1186/s13613-021-00976-5 · Cited by 81 · see citing works

Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

Ilett, E. E., Jørgensen, M., Noguera-Julián, M., Nørgaard, J. C., Daugaard, G., Helleberg, M., Paredes, R., Murray, D. D., Lundgren, J. D., MacPherson, C. R., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002677 · Cited by 74 · see citing works

Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement

Fabozzi, F., Trovato, C. M., Diamanti, A., Mastronuzzi, A., Zecca, M., Tripodi, S. I., Masetti, R., Leardini, D., Muratore, E., Barat, V., et al. (2022) · Cancers · doi:10.3390/cancers14143378 · Cited by 73 · see citing works

Roles of the intestinal microbiota and microbial metabolites in acute GVHD

Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology &amp; Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71 · see citing works

Nonclassical manifestations of acute GVHD

Zeiser, R., & Teshima, T. (2021) · Blood · doi:10.1182/blood.2021012431 · Cited by 69 · see citing works

Gut microbiome in pediatric acute leukemia: from predisposition to cure

Masetti, R., Muratore, E., Leardini, D., Zama, D., Turroni, S., Brigidi, P., Esposito, S., & Pession, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005129 · Cited by 70 · see citing works

Lytic Bacteriophages Facilitate Antibiotic Sensitization of Enterococcus faecium

Canfield, G. S., Chatterjee, A., Espinosa, J., Mangalea, M. R., Sheriff, E. K., Keidan, M., McBride, S. W., McCollister, B. D., Hang, H. C., & Duerkop, B. A. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-21 · Cited by 65 · see citing works

Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

Lindner, S., Miltiadous, O., Ramos, R. J. J. F., Paredes, J., Kousa, A. I., Dai, A., Fei, T., Lauder, E., Frame, J., Waters, N. R., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01617-w · Cited by 68 · see citing works

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

Prasad, R., Rehman, A., Rehman, L., Darbaniyan, F., Blumenberg, V., Schubert, M., Mor, U., Zamir, E., Schmidt, S., Hayase, T., et al. (2024) · Blood · doi:10.1182/blood.2024025366 · Cited by 66 · see citing works

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Masetti, R., Leardini, D., Muratore, E., Fabbrini, M., D’Amico, F., Zama, D., Baccelli, F., Gottardi, F., Belotti, T., Ussowicz, M., et al. (2023) · Blood · doi:10.1182/blood.2023020026 · Cited by 67 · see citing works

Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease

Docampo, M. D., da Silva, M. B., Lazrak, A., Nichols, K. B., Lieberman, S. R., Slingerland, A. E., Armijo, G. K., Shono, Y., Nguyen, C. L., Monette, S., et al. (2021) · Blood · doi:10.1182/blood.2021010719 · Cited by 60 · see citing works

Mapping the early life gut microbiome in neonates with critical congenital heart disease: multiomics insights and implications for host metabolic and immunological health

Huang, Y., Lu, W., Zeng, M., Hu, X., Su, Z., Liu, Y., Liu, Z., Yuan, J., Li, L., Zhang, X., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01437-2 · Cited by 59 · see citing works

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease

van Lier, Y. F., Vos, J., Blom, B., & Hazenberg, M. D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2178805 · Cited by 60 · see citing works

Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

Malard, F., Loschi, M. L., Huynh, A., Cluzeau, T., Guenounou, S., Legrand, F., Magro, L., Orvain, C., Charbonnier, A., Panz-Klapuch, M., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102111 · Cited by 57 · see citing works

High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients

Nguyen, C. L., Markey, K. A., Miltiadous, O., Dai, A., Waters, N. R., Sadeghi, K. D., Fei, T., Shouval, R., Taylor, B. P., Liao, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.007 · Cited by 58 · see citing works

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

Shouval, R., Eshel, A., Dubovski, B., Kuperman, A. A., Danylesko, I., Fein, J. A., Fried, S., Geva, M., Kouniavski, E., Neuman, H., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001827 · Cited by 56 · see citing works

Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus

Isaac, S., Flor‐Duro, A., Carruana, G., Puchades‐Carrasco, L., Quirant, A., López‐Nogueroles, M., Pineda‐Lucena, A., Garcia‐Garcerà, M., & Úbeda, C. (2022) · Nature Communications · doi:10.1038/s41467-022-35380-5 · Cited by 53 · see citing works

The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy

Piccioni, A., Spagnuolo, F., Candelli, M., Voza, A., Covino, M., Gasbarrini, A., & Franceschi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206082 · Cited by 56 · see citing works

Microbiome-intestine cross talk during acute graft-versus-host disease

Rafei, H., & Jenq, R. R. (2020) · Blood · doi:10.1182/blood.2019000950 · Cited by 55 · see citing works

Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation

Khuat, L. T., Le, C. T., Pai, C.-C. S., Shields‐Cutler, R. R., Holtan, S. G., Rashidi, A., Parker, S. L., Knights, D., Luna, J. I., Dunai, C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7713 · Cited by 52 · see citing works

Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity

Koyama, M., Hippe, D. S., Srinivasan, S., Proll, S. C., Miltiadous, O., Li, N., Zhang, P., Ensbey, K. S., Hoffman, N. G., Schmidt, C. R., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.024 · Cited by 53 · see citing works

Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect

Reddi, S., Senyshyn, L., Ebadi, M., Podlesny, D., Minot, S. S., Gooley, T. A., Kabage, A. J., Hill, G. R., Lee, S. J., Khoruts, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56375-y · Cited by 53 · see citing works

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

Ponce, D. M., Alousi, A. M., Nakamura, R., Slingerland, J. B., Calafiore, M., Sandhu, K., Barker, J. N., Devlin, S. M., Shia, J., Giralt, S., et al. (2022) · Blood · doi:10.1182/blood.2021015111 · Cited by 51 · see citing works

Microbiota-derived metabolites: Key modulators of cancer immunotherapies

Perl, M., Fante, M. A., Herfeld, K., Scherer, J. N., Poeck, H., & Orberg, E. T. (2025) · Med · doi:10.1016/j.medj.2025.100773 · Cited by 51 · see citing works

An enterococcal phage-derived enzyme suppresses graft-versus-host disease

Fujimoto, K., Hayashi, T., Yamamoto, M., Sato, N., Shimohigoshi, M., Miyaoka, D., Yokota, C., Watanabe, M., Hisaki, Y., Kamei, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07667-8 · Cited by 49 · see citing works

Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation

Shouval, R., Waters, N. R., Gomes, A. L. C., Brambilla, C. Z., Fei, T., Devlin, S. M., Nguyen, C. L., Markey, K. A., Dai, A., Slingerland, J. B., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1254 · Cited by 49 · see citing works

Global diversity of enterococci and description of 18 previously unknown species

Schwartzman, J. A., Lebreton, F., Salamzade, R., Shea, T., Martin, M. J., Schaufler, K., Urhan, A., Abeel, T., Camargo, I. L. B. D. C., Sgardioli, B. F., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310852121 · Cited by 54 · see citing works

The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant

Devaux, C. A., Million, M., & Raoult, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01642 · Cited by 49 · see citing works

Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium

Li, Q., Chen, S., Zhu, K., Huang, X., Huang, Y., Shen, Z., Ding, S., Gu, D., Yang, Q., Sun, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29493-0 · Cited by 44 · see citing works

Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients

Liao, C., Taylor, B. P., Ceccarani, C., Fontana, E., Amoretti, L. A., Wright, R. J., Gomes, A. L. C., Peled, J. U., Taur, Y., Perales, M., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-00860-8 · Cited by 45 · see citing works

A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial

Andermann, T. M., Fouladi, F., Tamburini, F. B., Sahaf, B., Tkachenko, E., Greene, C., Buckley, M. T., Brooks, E. F., Hedlin, H., Arai, S., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.07.009 · Cited by 44 · see citing works

Peptidoglycan NlpC/P60 peptidases in bacterial physiology and host interactions

Griffin, M. E., Klupt, S., Espinosa, J., & Hang, H. C. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.11.001 · Cited by 46 · see citing works

Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis

Riwes, M. M., & Reddy, P. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.06.001 · Cited by 44 · see citing works

Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation

Čierniková, S., Kasperová, B. J., Drgoňa, Ľ., Smolková, B., Števurková, V., & Mego, M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100790 · Cited by 43 · see citing works

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant

Miltiadous, O., Waters, N. R., Andrlová, H., Dai, A., Nguyen, C. L., da Silva, M. B., Lindner, S., Slingerland, J., Giardina, P., Clurman, A., et al. (2022) · Blood · doi:10.1182/blood.2021014255 · Cited by 43 · see citing works

Enterococci facilitate polymicrobial infections

Xu, W., Fang, Y., & Zhu, K. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.07.010 · Cited by 42 · see citing works

Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease

Socié, G., Kean, L. S., Zeiser, R., & Blazar, B. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149296 · Cited by 42 · see citing works

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Buxbaum, N. P., Socié, G., Hill, G. R., MacDonald, K. P. A., Tkachev, V., Teshima, T., Lee, S. J., Ritz, J., Sarantopoulos, S., Luznik, L., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007611 · Cited by 41 · see citing works

Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation

Seike, K., Kiledal, E. A., Fujiwara, H., Henig, I. J., da Silva, M. B., van den Brink, M. R. M., Hein, R., Hoostal, M. J., Liu, C., Oravecz-Wilson, K. I., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.007 · Cited by 42 · see citing works

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Rashidi, A., Gao, F., Fredricks, D. N., Pergam, S. A., Mielcarek, M. B., Milano, F., Sandmaier, B. M., & Lee, S. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17188 · Cited by 40 · see citing works

Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease

Yue, X., Zhou, H., Wang, S., Chen, X., & Xiao, H. (2024) · Cancer Medicine · doi:10.1002/cam4.6799 · Cited by 42 · see citing works

Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation

Shi, B., Li, H., & He, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323237 · Cited by 42 · see citing works

Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation

Meedt, E., Hiergeist, A., Gessner, A., Dettmer, K., Liebisch, G., Ghimire, S., Poeck, H., Edinger, M., Wolff, D., Herr, W., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab500 · Cited by 40 · see citing works

Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients

Muratore, E., Leardini, D., Baccelli, F., Venturelli, F., Prete, A., & Masetti, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.993668 · Cited by 40 · see citing works

Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation

Orberg, E. T., Meedt, E., Hiergeist, A., Xue, J., Heinrich, P., Ru, J., Ghimire, S., Miltiadous, O., Lindner, S., Tiefgraber, M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00669-x · Cited by 42 · see citing works

Children and adults should avoid consuming animal products to reduce risk for chronic disease: NO

Leroy, F., & Barnard, N. D. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa236 · Cited by 39 · see citing works

Current practice in nutrition after allogeneic hematopoietic stem cell transplantation – Results from a survey among hematopoietic stem cell transplant centers

Toenges, R., Greinix, H., Lawitschka, Á., Halter, J. P., Baumgartner, A., Simon, A., Arends, J., Jäger, P. S., Middeke, M., Hilgendorf, I., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.030 · Cited by 39 · see citing works

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy

Schubert, M., Rohrbach, R., Schmitt, M. W., & Stein‐Thoeringer, C. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670286 · Cited by 39 · see citing works

CAR-T Cell Therapy and the Gut Microbiota

Asokan, S., Cullin, N., Stein‐Thoeringer, C. K., & Elinav, E. (2023) · Cancers · doi:10.3390/cancers15030794 · Cited by 39 · see citing works

Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance

Hong, T., Wang, R., Wang, X., Yang, S., Wang, W., Gao, Q., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644982 · Cited by 38 · see citing works

Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice

Malard, F., Gaugler, B., & Mohty, M. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00223-x · Cited by 37 · see citing works

Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial

Rashidi, A., Ebadi, M., Rehman, T. U., Elhusseini, H., Kazadi, D., Halaweish, H., Khan, M. H., Hoeschen, A. L., Cao, Q., Luo, X., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2369 · Cited by 37 · see citing works

Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease

Sanchez, J. F., Maknojia, A., & King, K. Y. (2024) · Blood · doi:10.1182/blood.2023021174 · Cited by 37 · see citing works

Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy

Tourret, M., Talvard-Balland, N., Lambert, M., Youssef, G. B., Chevalier, M. F., Bohineust, A., Yvorra, T., Morin, F., Azarnoush, S., Lantz, O. J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003123 · Cited by 37 · see citing works

Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation

Michniacki, T. F., Choi, S. W., & Peltier, D. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_544 · Cited by 34 · see citing works

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease

Hayase, E., Hayase, T., Mukherjee, A., Stinson, S. C., Jamal, M. A., Ortega, M. R., Sanchez, C. A., Ahmed, S., Karmouch, J. L., Chang, C.-C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.08.004 · Cited by 36 · see citing works

Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Kusakabe, S., Fukushima, K., Yokota, T., Hino, A., Fujita, J., Motooka, D., Nakamura, S., Shibayama, H., & Kanakura, Y. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.01.019 · Cited by 34 · see citing works

Translating Microbiome Research From and To the Clinic

Zhang, Z. J., Lehmann, C. J., Cole, C. G., & Pamer, E. G. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-022206 · Cited by 32 · see citing works

The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation

Henig, I. J., Yehudai‐Ofir, D., & Zuckerman, T. (2020) · Haematologica · doi:10.3324/haematol.2020.247395 · Cited by 34 · see citing works

The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models

Teshima, T., & Hill, G. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715424 · Cited by 33 · see citing works

Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Masetti, R., D’Amico, F., Zama, D., Leardini, D., Muratore, E., Ussowicz, M., Frączkiewicz, J., Cesaro, S., Caddeo, G., Pezzella, V., et al. (2022) · Cancers · doi:10.3390/cancers14081932 · Cited by 33 · see citing works

Food ingredients in human health: Ecological and metabolic perspectives implicating gut microbiota function

Wu, Q., Chen, T., El-Nezami, H. S., & Savidge, T. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.04.007 · Cited by 31 · see citing works

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome

Li, X., Lin, Y., Li, X., Xu, X., Zhao, Y., Xu, L., Gao, Y., Li, Y., Tan, Y., Qian, P., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103048 · Cited by 34 · see citing works

Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease

Qiao, X., Biliński, J., Wang, L., Yang, T., Luo, R., Fu, Y., & Yang, G. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01824-1 · Cited by 32 · see citing works

Emerging roles of the gut microbiota in cancer immunotherapy

Shi, Z., Li, H., Song, W., Zhou, Z., Li, Z., & Zhang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139821 · Cited by 32 · see citing works

Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD

Jarosch, S., Köhlen, J., Ghimire, S., Orberg, E. T., Hammel, M., Gaag, D., Evert, M., Janssen, K., Hiergeist, A., Gessner, A., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101125 · Cited by 31 · see citing works

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

Gao, M., Hong, Y., Zhao, X., Pan, X., Sun, Y., Kong, J., Wang, Z., Wang, F., Wang, J., Yan, C.-H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720354 · Cited by 31 · see citing works

Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome

Ghani, R., Chrysostomou, D., Roberts, L. A., Pandiaraja, M., Marchesi, J. R., & Mullish, B. H. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2423026 · Cited by 31 · see citing works

Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection

Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Peng, X., Parvathy, S. N., Chen, Y., Silverman, M., & Routy, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00421 · Cited by 31 · see citing works

Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Heidrich, V., Bruno, J. S., Knebel, F. H., de Molla, V. C., Miranda‐Silva, W., Asprino, P. F., Tucunduva, L. T. C. D. M., Rocha, V., Novis, Y. A. S., Arrais‐Rodrigues, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692225 · Cited by 30 · see citing works

Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation

Masetti, R., Zama, D., Leardini, D., Muratore, E., Turroni, S., Brigidi, P., & Pession, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031197 · Cited by 30 · see citing works

The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma

Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 28 · see citing works

Lactose can fuel GVHD

Kelly, P. N. (2019) · Science · doi:10.1126/science.366.6469.1090-f

Enterococcus in Graft-versus-Host Disease

Garrett, W. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr1915978 · Cited by 9 · see citing works

Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd

Stein‐Thoeringer, C. K., Peled, J. U., Gomes, A. L. C., Lazrak, A., Docampo, M. D., Slingerland, A. E., Nichols, K. B., Shono, Y., Weber, D., Sung, A. D., et al. (2018) · Blood · doi:10.1182/blood-2018-99-119887 · Cited by 4 · see citing works

The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant

Devaux, C. A., Million, M., & Raoult, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01642 · Cited by 49 · see citing works

Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation

Lindner, S., & Peled, J. U. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000616 · Cited by 6 · see citing works